AAAAAA

   
Results: 1-8 |
Results: 8
Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients
Authors: Penson, MG Fricker, FJ Thompson, JR Harker, K Williams, BJ Kahler, DA Schowengerdt, KO
Citation: Mg. Penson et al., Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients, J HEART LUN, 20(6), 2001, pp. 611-618
Clinical and molecular studies of a large family with desmin-associated restrictive cardiomyopathy
Authors: Zhang, J Kumar, A Stalker, HJ Virdi, G Ferrans, VJ Horiba, K Fricker, FJ Wallace, MR
Citation: J. Zhang et al., Clinical and molecular studies of a large family with desmin-associated restrictive cardiomyopathy, CLIN GENET, 59(4), 2001, pp. 248-256
Glucocorticoid-induced osteopenia in adolescent heart transplant recipients
Authors: Braith, RW Howard, C Fricker, FJ Mitchell, M Edwards, DG
Citation: Rw. Braith et al., Glucocorticoid-induced osteopenia in adolescent heart transplant recipients, J HEART LUN, 19(9), 2000, pp. 840-845
Increased expression of the lymphocyte early activation marker CD69 in peripheral blood correlates with histologic evidence of cardiac allograft rejection
Authors: Schowengerdt, KO Fricker, FJ Bahjat, KS Kuntz, ST
Citation: Ko. Schowengerdt et al., Increased expression of the lymphocyte early activation marker CD69 in peripheral blood correlates with histologic evidence of cardiac allograft rejection, TRANSPLANT, 69(10), 2000, pp. 2102-2107
Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy
Authors: Helton, E Darragh, R Francis, P Fricker, FJ Jue, K Koch, G Mair, D Pierpont, ME Prochazka, JV Linn, LS Winter, SC
Citation: E. Helton et al., Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy, PEDIATRICS, 105(6), 2000, pp. 1260-1270
Transcatheter closure of modified Blalock-Taussig shunt with Gianturco-Grifka vascular occlusion device
Authors: Hoyer, MH Leon, RA Fricker, FJ
Citation: Mh. Hoyer et al., Transcatheter closure of modified Blalock-Taussig shunt with Gianturco-Grifka vascular occlusion device, CATHET C IN, 48(4), 1999, pp. 365-367
Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients
Authors: Penson, MG Winter, WE Fricker, FJ Harker, K Kahler, DA Kubilis, PS Schowengerdt, KO
Citation: Mg. Penson et al., Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients, J HEART LUN, 18(7), 1999, pp. 707-713
Dobutamine stress echocardiography: Experience in pediatric heart transplant recipients
Authors: Pahl, E Crawford, SE Swenson, JM Duffy, CE Fricker, FJ Backer, CL Mavroudis, C Chaudhry, FA
Citation: E. Pahl et al., Dobutamine stress echocardiography: Experience in pediatric heart transplant recipients, J HEART LUN, 18(7), 1999, pp. 725-732
Risultati: 1-8 |